Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study.

Rama Al HamedMaud NgoyaJacques-Emmanuel GalimardHenrik SengeloevTobias Gedde-DahlAleksandr KulaginUwe PlatzbeckerIbrahim Yakoub-AghaJenny L ByrneThomas ValeriusGerard SocieNicolaus KrögerDidier BlaiseAli BazarbachiJaime SanzFabio CiceriArnon NaglerMohamad Mohty

Published in: Cancer (2023)

Even in the absence of an MSD, outcomes of allo-HCT in CR2 for AML have significantly improved over time, with most favorable outcomes achieved with a MUD.

Keyphrases

acute myeloid leukemia
stem cell transplantation
bone marrow
allogeneic hematopoietic stem cell transplantation
type diabetes
cell proliferation
disease activity
cell death
stem cells
low dose
systemic lupus erythematosus
acute lymphoblastic leukemia
peripheral blood
rheumatoid arthritis